Prospectively recorded and MedDRA-coded safety data of intravenous methylprednisolone therapy in Graves’ orbitopathy

Conclusions Prospective and standardized evaluation with MedDRA and the ICH guideline demonstrated the good pharmacological tolerance and low morbidity of this moderate steroid regimen.

http://link.springer.com/10.1007/s40618-014-0227-x

Source: Journal of Endocrinological Investigation - January 10, 2015 Category: Endocrinology Source Type: research